A "systems medicine" approach to the study of non-alcoholic fatty liver disease.
about
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightMitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics ApproachNon-alcoholic fatty liver disease: An expanded reviewNAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver DiseaseThe Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.Repurposing Pentoxifylline for the Treatment of Fibrosis: An Overview.Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics.Regulation of retinol-binding protein 4 and retinol metabolism in fatty liver disease.NAFLD: Is There Anything New under the Sun?Nonalcoholic fatty liver disease: Evolving paradigms.Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS.Computational Modeling in Liver Surgery.A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression.Clinical relevance of liver histopathology and different histological classifications of NASH in adults.Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research.LiverSex Computational Model: Sexual Aspects in Hepatic Metabolism and Abnormalities.Rho, a Fraction From Rhodiola crenulate, Ameliorates Hepatic Steatosis in Mice Models.
P2860
Q26752583-09B2D08B-88CF-4D65-846F-22D01EBDE0F3Q26753043-8A73D8B6-6EEE-4116-9B35-DCCBF488B4A8Q33789868-3AF7E1A8-7718-47BD-ADCA-C69CC0CE4D81Q33844463-46C93CA2-F0BD-4EDF-B0A3-43128C07E6CDQ36138443-049C7426-CB08-4EA5-816D-B3866F80287FQ38752520-C0674AAE-F770-4EEF-9B15-AB115C486FEBQ39292948-24B62C68-123E-44AA-83FA-6848DFA6FAA0Q41552560-08F6FCCD-DE92-4236-A428-2F22C8CF835FQ42361308-04634310-8D89-49D2-8283-AF07146A2D0AQ42365749-F7BFCA2A-C5D7-4910-8B41-3FA0D404F931Q42695154-233B2442-2BD4-4FD9-9904-A23A0AB2873AQ46003417-D717F5DE-9FF3-4DD7-99DF-F6DC807CF593Q47145823-826CDE59-587C-4BB1-971E-507C082B7C6FQ47552953-5775E460-C7F7-4AB2-8CD4-E62BD260094FQ47581786-A81557E3-961F-417C-8F0F-8EEC143A7CEEQ48127172-0C30A2D8-3825-4BD5-925B-46DF9D94F5C3Q48196520-75730980-D4C7-420A-9E71-9BAAEA592047Q52661700-0CE45AA5-49C9-4820-9834-7EEE3FE31363Q55192876-2C5A338D-32D1-4927-AFDD-EC57D8306776Q55278642-3BBBB6E4-0A0D-4972-BAD9-1BEA60268E6D
P2860
A "systems medicine" approach to the study of non-alcoholic fatty liver disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A "systems medicine" approach to the study of non-alcoholic fatty liver disease.
@en
type
label
A "systems medicine" approach to the study of non-alcoholic fatty liver disease.
@en
prefLabel
A "systems medicine" approach to the study of non-alcoholic fatty liver disease.
@en
P2093
P1476
A "systems medicine" approach to the study of non-alcoholic fatty liver disease.
@en
P2093
Giovanni Targher
Luca Valenti
Salvatore Petta
Special Interest Group on Pers ...... iation for Study of Liver AISF
Special Interest Group on Pers ...... the Study of the Liver (AISF)
Stefano Bellentani
P304
P356
10.1016/J.DLD.2015.10.027
P577
2015-11-14T00:00:00Z